In response to EGF, active EGFR induces N-glycosyltransferase B3GNT3 expression, leading to B3GNT3-mediated glycosylation of PD-L1, which subsequently inhibits PD-L1 degradation resulting in immunosuppression in a breast xenograft tumor model31. This evidence concerns the gene CD274 and neoplasm.